Navigation Links
Orexigen Resubmits Contrave New Drug Application
Date:12/11/2013

ection with the review of the MAA; even if the NDA is approved by the FDA, the final results of the Light Study may not support continued approval of Contrave; the therapeutic and commercial value of Contrave; and other risks described in Orexigen's filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward‐looking statements, which speak only as of the date hereof, and Orexigen undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof. Further information regarding these and other risks is included under the heading "Risk Factors" in Orexigen's Current Report on Form 8-K filed with the Securities and Exchange Commission December 2, 2013 and its other reports, which are available from the SEC's website (www.sec.gov) and on Orexigen's website (www.orexigen.com) under the heading "Investor Relations." All forward‐looking statements are qualified in their entirety by this cautionary statement. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.Orexigen Contact: Media Contact: McDavid Stilwell

Denise PowellVP, Corporate Communications and Business Development

BrewLife(858) 875-8629

(510) 703-9491


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Orexigen Therapeutics, Inc. Announces the Closing of its Offering of $115 Million of Convertible Senior Notes
2. Orexigen Therapeutics to Present at the 25th Annual Piper Jaffray Healthcare Conference
3. Orexigen Announces Successful Interim Analysis of Contrave Light Study
4. Orexigen Therapeutics to Host Contrave Light Study Interim Analysis Conference Call and Webcast
5. Orexigen Therapeutics Reports Business and Financial Results for the Third Quarter Ended September 30, 2013
6. Orexigen and Takeda Announce Multiple Contrave Data Presentations at the ObesityWeek Meeting in Atlanta
7. Orexigen Therapeutics Enters Into Agreement with Sanofi to Manufacture Contrave for Territories Outside North America
8. A Balanced Risk-Benefit Profile Will Propel Orexigen/Takedas Contrave to Become the Most Widely Used Emerging Therapy for the Treatment of Obese and Overweight Patients
9. Orexigen Therapeutics Announces Date of Third Quarter 2013 Financial Results Conference Call and Upcoming Presentation at Credit Suisse Healthcare Conference
10. Orexigen Therapeutics to Present at the Bank of America Merrill Lynch Global Healthcare Conference
11. Orexigen Therapeutics Announces European Filing Strategy and Reports Business and Financial Results for the Second Quarter Ended June 30, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... , May 4, 2015  Verus Healthcare, Inc. ... acquisition of CPAP Care Club in 2012.  Since that ... within the durable medical equipment (DME) industry by 1,000%.  ... for their CPAP supply needs and processes nearly 14,000 ... this company three years ago, the systems and processes ...
(Date:5/4/2015)... , May 4, 2015 ... Market by Scope (Rigid (Laparoscope, Ureteroscope), Flexible (Colonoscope, Gastroscope), ... by Application (Colonoscopy, Laparoscopy, Arthroscopy) - Global Forecasts to ... expected to reach $19.0 Billion by 2019 with a ... to 2019). Browse   127   ...
(Date:5/4/2015)... 2015 /PRNewswire/ - YOLO Medical Inc. , ... distribution of medical and aesthetic devices, proudly announces ... YOLO,s new generation body contouring laser system; LIPOFINA. ... second-generation low-level laser device for body contouring, creating ... patented technology while continuing to push the envelope ...
Breaking Medicine Technology:Verus Healthcare Celebrates 1,000% Growth on Third Anniversary 2The Medical Videoscope Market Worth $19.0 Billion by 2019 2The Medical Videoscope Market Worth $19.0 Billion by 2019 3The Medical Videoscope Market Worth $19.0 Billion by 2019 4The Medical Videoscope Market Worth $19.0 Billion by 2019 5YOLO Medical Inc. receives FDA clearance for body contouring laser 2
... 2011 Reportlinker.com announces that a new ... its catalogue: Immunotherapy ... http://www.reportlinker.com/p0284906/Immunotherapy-in-Oncology-Drug-Pipeline-Update-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biological_Therapy ... attractive therapeutic addition, delivering treatment of ...
... Scotland, September 7, 2011 The Astellas European ... Transplantation Grant: Dr Christian Toso of the University ... led by Dr Toso, received the grant of US$ 300,000 ... tailored immuno - suppression after liver transplantation for ...
Cached Medicine Technology:Immunotherapy in Oncology Drug Pipeline Update 2011 2Immunotherapy in Oncology Drug Pipeline Update 2011 3Immunotherapy in Oncology Drug Pipeline Update 2011 4Immunotherapy in Oncology Drug Pipeline Update 2011 5Immunotherapy in Oncology Drug Pipeline Update 2011 6Immunotherapy in Oncology Drug Pipeline Update 2011 7The Astellas European Foundation Winner of Transplantation Grant 2011 Announced 2
(Date:5/4/2015)... 2015 New findings released today from ... (ABTA) show that people diagnosed with a brain tumor ... including clinical trials, at the time of diagnosis, and ... decisions about their course of treatment. The release of ... nationwide brain tumor volunteer network, the ABTA CommYOUnity™, dedicated ...
(Date:5/4/2015)... 2015 Dr. Benjamin Stong of Kalos ... the latest non-surgical double-chin eliminator. Dr. Stong is ... in Atlanta to offer Kybella treatments . The ... specifically under the chin, promising to safely dissolve fat ... patients who sought immediate solutions for their double chin ...
(Date:5/4/2015)... May 04, 2015 In response ... Preventive Services Task Force (USPSTF), Strategic Radiology® (SR®) ... Congress of Obstetricians and Gynecologists (ACOG), the American ... Cure, American Cancer Society (ACS), American College of ... to unanimously recommend regular screening mammography for women ...
(Date:5/4/2015)... “ Food Cost Calculator ” was featured on NewsWatch ... at the latest and coolest applications on the market for ... and technology expert, conducted the app review and shared with ... efficiently calculate food costs. , The restaurant industry is a ... has an estimated 1.8 trillion dollar impact on the US ...
(Date:5/4/2015)... San Diego, CA (PRWEB) May 04, 2015 ... New Cireson Platform to ... Cireson offers customers a choice to consume Microsoft ... cloud or Hyper-V on premise , Company ... focused model , Continuous innovation with expanding ...
Breaking Medicine News(10 mins):Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3Health News:Facial Plastic Surgeon First in Atlanta To Offer Kybella Treatments To Reduce Chin Fat 2Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 2Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 3Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 4Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 5Health News:An Application to Manage a Successful Restaurant Was Featured on NewsWatch Television 2Health News:Cireson Unveils New Microsoft Cloud & System Center Strategy 2Health News:Cireson Unveils New Microsoft Cloud & System Center Strategy 3Health News:Cireson Unveils New Microsoft Cloud & System Center Strategy 4
... 4 Crdentia Corp. (OTC Bulletin,Board: CRDT), ... services,today announced the appointment of Mr. Randall ... Chief Clinical Officer. In this newly created,position, ... compliance and accreditation, assisting in business,plan development ...
... Online Resource to Support Journal Editors Handling ... of scientific, technical and,medical information products and ... Ethics Resource Kit (PERK),( http://www.elsevier.com/publishingethicskit )., ... in Singapore, Mark,Seeley, Senior Vice President and ...
... 4 Seniors have done their share.,Millions stepped ... insurance and state government have failed to stop,runaway ... rich coverage have,been forced to lapse their policies. ... approval and endorsement., Last week,s Wall Street ...
... nutrient education, WHITE PLAINS, N.Y., March 4 Despite ... to take drastic measures to lose,weight, with one third saying ... lose a few pounds, a recent survey found., Although ... of the time or more often, many do not fully ...
... report they are not getting the sleep they need ... may contribute to their inadequate sleep. The survey, issued ... (ACCP-SI), found that most physicians sleep fewer hours than ... believe their work schedules do not allow for adequate ...
... cellular pathways involved in cancer metastasis , , MONDAY, March ... regulates development of human embryonic stem cells can inhibit ... breast cancers, says a study by researchers at Northwestern ... week,s online issue of the Proceedings of the ...
Cached Medicine News:Health News:Crdentia Appoints Randall Turnbull to Senior Vice President and Chief Clinical Officer 2Health News:Crdentia Appoints Randall Turnbull to Senior Vice President and Chief Clinical Officer 3Health News:Elsevier Launches Publishing Ethics Resource Kit 2Health News:State Governments are Snookering Seniors 2Health News:New Survey Shows 90 Percent of Women Do Not Fully Understand the Calories They Eat 2Health News:New Survey Shows 90 Percent of Women Do Not Fully Understand the Calories They Eat 3Health News:Physicians report they need more sleep 2Health News:Physicians report they need more sleep 3Health News:Embryonic Stem Cell Protein Inhibits Melanoma 2
... Flexible Ureteroscope (DUR-D) incorporates many of ... durable, market leading DUR® series flexible ... device utilizing Gyrus ACMIs proprietary, worlds ... Oxide Semi-Conductor (CMOS) distal sensor technology ...
... new ImmunoCard STAT! EHEC is the first one-step ... Shiga Toxin 1 and 2 produced by Enterohemorrhagic ... on McConkey broth overnight enrichment of fecal specimens ... and 100% specificity., The separate result for Toxin ...
Inquire...
... elegant and sophisticated woman, the ... ophthalmic and sunwear styles. Frames ... of shapes and colors, designed ... and complexions. Many styles feature ...
Medicine Products: